181 related articles for article (PubMed ID: 17917406)
1. Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease.
Attia N; Nakbi A; Smaoui M; Chaaba R; Moulin P; Hammami S; Hamda KB; Chanussot F; Hammami M
Tohoku J Exp Med; 2007 Oct; 213(2):129-37. PubMed ID: 17917406
[TBL] [Abstract][Full Text] [Related]
2. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: a potentially adverse effect on reverse cholesterol transport.
Dullaart RP; van Tol A
Diabet Med; 2001 Jun; 18(6):509-13. PubMed ID: 11472472
[TBL] [Abstract][Full Text] [Related]
3. Rates of cholesterol esterification and esterified cholesterol net mass transfer between high-density lipoproteins and apolipoprotein B-containing lipoproteins in Type 1 diabetes.
Valabhji J; Donovan J; McColl AJ; Schachter M; Richmond W; Elkeles RS
Diabet Med; 2002 May; 19(5):424-8. PubMed ID: 12027932
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
Plomgaard P; Dullaart RP; de Vries R; Groen AK; Dahlbäck B; Nielsen LB
J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.
Dullaart RP; Groen AK; Dallinga-Thie GM; de Vries R; Sluiter WJ; van Tol A
Eur J Endocrinol; 2008 Jan; 158(1):53-60. PubMed ID: 18166817
[TBL] [Abstract][Full Text] [Related]
6. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
de Vries R; Groen AK; Perton FG; Dallinga-Thie GM; van Wijland MJ; Dikkeschei LD; Wolffenbuttel BH; van Tol A; Dullaart RP
Atherosclerosis; 2008 Feb; 196(2):733-41. PubMed ID: 17275009
[TBL] [Abstract][Full Text] [Related]
7. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
Vogt L; Laverman GD; van Tol A; Groen AK; Navis G; Dullaart RP
Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
[TBL] [Abstract][Full Text] [Related]
8. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
Riemens S; van Tol A; Sluiter W; Dullaart R
Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
[TBL] [Abstract][Full Text] [Related]
9. Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects.
Dullaart RP; van Tol A
Scand J Clin Lab Invest; 2001 Feb; 61(1):69-74. PubMed ID: 11300613
[TBL] [Abstract][Full Text] [Related]
10. Twenty four hour insulin infusion impairs the ability of plasma from healthy subjects and Type 2 diabetic patients to promote cellular cholesterol efflux.
Dullaart RP; van Tol A
Atherosclerosis; 2001 Jul; 157(1):49-56. PubMed ID: 11427203
[TBL] [Abstract][Full Text] [Related]
11. Liver phospholipid transfer protein (PLTP) expression with a PLTP-null background promotes very low-density lipoprotein production in mice.
Yazdanyar A; Jiang XC
Hepatology; 2012 Aug; 56(2):576-84. PubMed ID: 22367708
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
13. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.
Jiang XC; Bruce C; Mar J; Lin M; Ji Y; Francone OL; Tall AR
J Clin Invest; 1999 Mar; 103(6):907-14. PubMed ID: 10079112
[TBL] [Abstract][Full Text] [Related]
14. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F
Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
[TBL] [Abstract][Full Text] [Related]
15. Elevation of systemic PLTP, but not macrophage-PLTP, impairs macrophage reverse cholesterol transport in transgenic mice.
Samyn H; Moerland M; van Gent T; van Haperen R; Grosveld F; van Tol A; de Crom R
Atherosclerosis; 2009 Jun; 204(2):429-34. PubMed ID: 19100548
[TBL] [Abstract][Full Text] [Related]
16. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
Dallinga-Thie GM; van Tol A; Dullaart RP;
Biochim Biophys Acta; 2009 Aug; 1791(8):714-8. PubMed ID: 19303940
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol efflux from Fu5AH hepatoma cells induced by plasma of subjects with or without coronary artery disease and non-insulin-dependent diabetes: importance of LpA-I:A-II particles and phospholipid transfer protein.
Syvänne M; Castro G; Dengremont C; De Geitere C; Jauhiainen M; Ehnholm C; Michelagnoli S; Franceschini G; Kahri J; Taskinen MR
Atherosclerosis; 1996 Dec; 127(2):245-53. PubMed ID: 9125315
[TBL] [Abstract][Full Text] [Related]
18. Plasma phospholipid transfer protein activity is related to insulin resistance: impaired acute lowering by insulin in obese Type II diabetic patients.
Riemens SC; van Tol A; Sluiter WJ; Dullaart RP
Diabetologia; 1998 Aug; 41(8):929-34. PubMed ID: 9726595
[TBL] [Abstract][Full Text] [Related]
19. Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.
Dullaart RP; Garcia E; Jeyarajah E; Gruppen EG; Connelly MA
Lipids Health Dis; 2016 Aug; 15(1):143. PubMed ID: 27581838
[TBL] [Abstract][Full Text] [Related]
20. Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.
Schlitt A; Schwaab B; Fingscheidt K; Lackner KJ; Heine GH; Vogt A; Buerke M; Maegdefessel L; Raaz U; Werdan K; Jiang XC
Lipids; 2010 Feb; 45(2):129-35. PubMed ID: 20108050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
